| 发明名称 |
HCV immunotherapy |
| 摘要 |
The invention relates to the use of lnterleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load. |
| 申请公布号 |
AU2012292032(A1) |
申请公布日期 |
2014.03.13 |
| 申请号 |
AU20120292032 |
申请日期 |
2012.08.02 |
| 申请人 |
CYTHERIS |
发明人 |
MORRE, MICHEL;ASSOULINE, BRIGITTE;CROUGHS, THERESE;DEMOL, PIERRE;BEQ, STEPHANIE |
| 分类号 |
A61K38/20;A61P1/16;A61P31/12 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
